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Introduction
 Cervical cancer is a major cause of death among 
women in developing countries where it accounts for 
about 13% of all female cancers (Globocan, 2008). 
The disease has largely been eliminated in high income 
countries with prophylactic immunization and secondary 
prevention (Gakidou et al., 2008; Demarteau et al., 2012). 
Introduction of the HPV vaccine has proceeded slowly 
in many countries because of low knowledge about 
cervical cancer, high vaccine cost, and cultural preferences 
surrounding vaccinating young girls (Tsui et al., 2009). 
HPV types 16 and/or 18, against which the vaccines are 
most effective (CDC, 2012), have been found to be present 
in 74% to nearly 90% of cervical cancer patients in India. 
(Basu et al., 2009; Das, 2013). Estimates suggest that 
prophylactic HPV vaccination can reduce the burden of 
cervical cancer in India by more than 75% (Basu et al., 
2009). According to the results of a cost-effectiveness 
analysis, 70% coverage of pre-adolescent girls (girls below 
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Abstract
 Background: Increasing uptake of human papillomavirus (HPV) vaccine should be a priority in developing 
countries since they suffer 88% of the world’s cervical cancer burden. In many countries studies show that age 
at vaccination is an important determinate of parental acceptability. This study explores parental preferences 
on age-to-vaccinate for adolescent school-going girls. Materials and Methods: The sample was selected using a 
two-stage probability proportional to size cluster sampling methodology. Questionnaires were sent home with a 
random sample of 800 adolescent girls attending 12 schools in Mysore to be completed by parents. Descriptive 
statistics including frequencies, percentages and proportions were generated for independent variables and 
bivariate analyses (Chi square test) were used to assess the relationship between independent and appropriate 
age-to-vaccinate. Results: HPV vaccination acceptability was high at 71%. While 5.3% of parents felt girls 
should be vaccinated by 10 years or younger; 38.3% said 11-15 years; 14.8% said 16-18 years; 5.8% suggested 
over 19 years; and 33% didn’t know.  Only 2.8% of parents would not vaccinate their daughters. Conclusions: 
'HOD\LQJ+39YDFFLQDWLRQXQWLOODWHUDJHVPD\VLJQLÀFDQWO\LQFUHDVHXSWDNHRIWKH+39YDFFLQHLQ,QGLD 
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age 12) with the HPV vaccine can potentially reduce 
the lifetime risk of cervical cancer by 44%; and is more 
effective than screening alone. Screening three times in a 
lifetime reduces cervical cancer risk by 21-33% (Diaz et 
al., 2008). Despite these facts, little research on vaccine 
acceptability has been carried out in India, a country with 
one of the highest incidence of cervical cancer in the 
world.
 Studies have shown that age-at-vaccination is an 
important factor in parental decision-making about 
immunizing daughter against HPV infection (Marlow 
et al., 2007). A qualitative study carried out in the 
same population suggested that many parents preferred 
vaccinating girls against HPV after puberty. Most felt 
that younger girls were unlikely to be sexually active and 
therefore should not receive an HPV vaccination until 
they were adolescents or young adults (Madhivanan et 
al., 2009). This manuscript describes a quantitative survey 
among parents of school going girls in urban Mysore about 
the most appropriate age at HPV vaccination.
Purnima Madhivanan et al
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Materials and Methods
 Between February and December 2010, a questionnaire 
survey was conducted among parents in a cluster of 12 
schools Mysore City, India. Participants were included if 
they had an adolescent school-going daughter (ages 11-
15) in target schools; were able to read and understand 
English or Kannada, the local language; and could give 
informed consent. 
 A program announcement was sent home with all 
girls attending 7th through 10th grades explaining the 
study and inviting eligible parents to participate. Then 
we enumerated all schoolgirls in the target age group and 
randomly selected 800 female students to take surveys 
home. The questionnaire that it should be completed 
by one parent per household and returned within seven 
days. The study was approved by the Institutional Review 
Committee of Public Health Research Institute of India 
and Florida International University. 
 Data were analyzed using Stata 10.1 (Stata Corporation, 
College Station, TX) and SAS statistical software package, 
version 9.3 (SAS Institute Inc., Cary, North Carolina). 
Issues related to cluster sampling was adjusted by using 
“proc surveyfreq” procedures. Descriptive statistics were 
conducted for all variables. Bivariate associations between 
preferred ‘age-of-vaccination’ and explanatory variables 
ZHUHDVVHVVHGXVLQJFKLVTXDUHGWHVWV7HVWVRIVLJQLÀFDQFH
were 2-tailed (p<0.05). 
Results 
 Of the 797 returned surveys, 19 were excluded from 
analyses because they were returned without a signed 
consent form. 298 parents (about 38.3%) preferred 
vaccinating their daughters between 11-15 years; 5.3%, 
10 years or younger; 20.6% favored late vaccination (16 
years or older) and 33% were unsure when to vaccinate 
(Figure 1). 
 Of the 43.6% of parents who thought the appropriate 
age to vaccinate was less than 15 years, 81% were likely to 
accept HPV vaccination for their daughter as compared to 
70% of those who thought the appropriate age to vaccinate 
was over 15 years of age. Interestingly, of the 35.9% 
of respondents who were unsure of appropriate age-to-
vaccinate, 60.6% also found HPV vaccination acceptable. 
 Table 1 describes the relationship of the demographic 
characteristics of the respondents with their preferred age 
of vaccination of girls with HPV vaccine. About 41% 
of Hindus, 51% Muslims and 64% of parents of other 
religions said they would consider early vaccination for 
their daughters (p=0.0009). There was no association with 
age-at-vaccination and other demographic characteristics 
of respondents. 
Age to discuss HPV and cancer with daughters
 Parents were asked the most appropriate age when they 
would discuss cancer with their daughters and cervical 
FDQFHUVSHFLÀFDOO\:KLOHRISDUHQWVZHUHZLOOLQJ
Table 1. Relationship of Demographic Characteristics Associated with Parents’ Preferred age at HPV Vaccination 
of Children (N =778) in Mysore City, India
Characteristic Preferred age of vaccination (n= 778) Total (%)d Chi-Square
 15 or less (%)a     Above 15 (%)b     Not sure (%)c  p value
$JHJURXS\HDUV      
 36-40 126 (49.0) 47 (18.3) 84 (34.71) 257 (32.7) 
 41-50 65 (41.4) 34 (21.7) 58 (36.9) 157 (20.2) 
 51-60 46  (37.7) 33 (27.0)  43 (35.2) 122 (15.7) 
Education level None  53 (45.7) 24 (20.7) 39 (33.6) 116 (14.9) 0.41
 1 to10th grade  167 (42.4) 80 (20.3) 147 (37.3) 394 (50.6) 
 High School & Bachelor degree  88 (46.6) 35 (18.5) 66 (34.9) 189 (24.3) 
 Master degree or above  15 (38.5) 13 (33.3) 11 (28.2) 39 (5.0) 
 Vocational Training (Diploma)  16 (40.0) 8 (20.0) 16 (40.0) 40 (5.1) 
Employment Status Employed full time 91 (42.5) 47 (22.0) 76 (35.5) 214 (27.5) 0.82
 Employed part-time 36 (43.4) 18 (21.7) 29 (34.9) 83 (10.7) 
 Self-employed 52 (46.4) 19 (17.0) 41 (36.6) 112 (14.4) 
 Full time home maker 147 (43.4) 73 (21.5) 119 (35.1) 339 (43.6) 
 Retired/Unemployed 13 (43.3) 3 (10.0) 14 (46.7) 30 (3.9) 
Marital Status Married 321 (43.6) 150 (20.4) 266 (36.1) 737 (94.7) 0.81
 Divorced/Separated/widowed 18(43.9) 10 (24.4) 13 (31.7) 41 (5.3) 
Religion Hindus 249 (41.0) 130 (21.4) 228 (37.6) 607 (78.0) 0.0009*
 Muslim 74 (50.7) 27 (18.5) 45 (30.8) 146 (18.8) 
 Christians/ others 16(64.0) 3(12.0) 6(24.0) 25 (3.2) 
VWDWLVWLFDOO\VLJQLÀFDQWaproportion of the parents within each category who prefer that age at HPV vaccination should be 15 years or less, bproportion of the parents 
within each category who prefer that age at HPV vaccination should be above 15 years, cproportion of the parents within each category, who are not sure of an appropriate 
age for HPV vaccination, bpercentage out of the total (N=778)
Figure 1. Distribution of Parents (N=778) According 
to the Age at which they Prefer Girls should Receive 
HPV Vaccine
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WRGLVFXVVFDQFHULQJHQHUDOZLWK\RXQJHUGDXJKWHUV
years); 25% of the parents were willing to discuss with 
daughters aged 11-14 years; and 35% between 15-18 
years. About 29% reported that girls should be over 18 
years before cancer is discussed. In contrast, only 3% were 
ZLOOLQJWRGLVFXVVFHUYLFDOFDQFHUVSHFLÀFDOO\ZLWKWKHLU
\RXQJHUDJHGDXJKWHUV$ERXWRQHLQÀYHZRXOGGLVFXVVLW
with 11-14 year olds, and 34% felt it was only appropriate 
for 15-18 year olds. Over 40% of the parents preferred 
discussing cervical cancer only if daughters were over 19 
years of age.
 :KHQDVNHGLISDUHQWVZRXOGGLVFXVVVH[LQJHQHUDO
DQGVH[XDOO\WUDQVPLWWHGLQIHFWLRQVVSHFLÀFDOO\PRUHWKDQ
half of the sample (60%) preferred waiting until their 
daughter was 19 years or older. About a third (30.1%) of 
participants reported they would consider talking to their 
child when she is 15-18 years of age. 
 Parents were asked about the appropriate time for 
discussing vaccinations in general, and HPV vaccination 
in particular, with their daughter. About one in five 
(20%) and one in 10 respectively were willing to discuss 
vaccinations in general and HPV vaccination with their 
younger age daughters. Less than one third of parents 
(27%) and 29% respectively, said they would talk to 
their 11-14 years about vaccination in general and HPV 
YDFFLQDWLRQVSHFLÀFDOO\$ERXWDQGVDLGWKH\
would talk to their 15-18 years about vaccinations in 
general and HPV vaccination in particular, respectively. 
Finally, 19% and 21% said they would only discuss 
vaccinations in general and HPV vaccine in particular 
with a daughter over age 19.
Information about vaccinations 
 Most parents (85%) reported television as their main 
way of getting information about vaccines; 79% said 
newspaper or radio; and 43%, the internet. In addition, 
86% of the parents reported doctors as their main source 
of information about vaccines; 60%, friends or neighbors; 
and 54%, other healthcare workers. A vast majority (82%) 
reported getting information from their daughter’s school 
on vaccinations, and 63% said they relied on family 
members or relatives for this information. 
Discussion
7KLV VWXG\ LV RQH RI WKH ÀUVW WR H[DPLQH SDUHQWDO
preferences about age of vaccination for HPV infection 
in southern India. The data shows that majority of parents 
felt that daughters should be vaccinated at older ages (11-
:KLOHRIUHVSRQGHQWVDOVRIHOWWKDWFDQFHUDQG
cervical cancer should not be discussed with a child until 
they are older (15-19 years). Finally, many parents receive 
their vaccine information from television (84.5%), or a 
family physician (86%).
The preference for vaccinating older children should 
not be overlooked in planning a rollout of the HPV 
YDFFLQH6LQFHWKHDYHUDJHDJHDWÀUVWLQWHUFRXUVHLV
years in India, immunizing at later ages is unlikely to 
reduce the effectiveness of the vaccine (Durex Network , 
2007). Our data shows that Indian parents would be more 
accepting of HPV immunization if it were given at later 
DJHV7KLV LV VLPLODU WRÀQGLQJV IURPUHVHDUFK LQRWKHU
countries, where, some studies have revealed parental 
willingness to vaccinate an older child compared to a 
younger one (Dempsey et al., 2006; Zhang et al., 2013).
Results of the study also suggest the importance of 
educating Pediatricians and Family physicians about HPV 
and cervical cancer. In addition, since a large percentage 
of parents get their information from television (85%) and 
the internet (43%), the vaccine should be aggressively 
promoted in these mediums.
This study had several limitations. First, because 
it utilized a sample of only parents of school-going 
DGROHVFHQW JLUOV ÀQGLQJVPD\QRW EH UHSUHVHQWDWLYH RI
the population as a whole. Even among parents of school-
going children, certain segments of the population may 
not have been represented in the institutions selected for 
study. The study also has important strengths including a 
high response rate, minimal missing data and a randomly 
selected study population. In conclusion, our study 
found Indian parents would be more accepting of HPV 
immunization if it were given at later ages. More studies 
are needed to examine parental acceptability and preferred 
age-to-vaccinate in different populations in India. 
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